What ICU Medical, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 13 | 19 |
| Total trades | 13 | 78 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 396,406 |
| Disposed | 37,518 | 258,953 |
| Net activity | −37,518 | +137,453 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sanzone Virginia Ruth | VP, General Counsel | Sep 03 | Disclosed 10b5-1 sale · S | −692 | $171.52 | −$119K | 14,604 |
| Sanzone Virginia Ruth | VP, General Counsel | Sep 03 | Disclosed 10b5-1 sale · S | −724 | $169.53 | −$123K | 15,296 |
| Sanzone Virginia Ruth | VP, General Counsel | Sep 03 | Disclosed 10b5-1 sale · S | −1,238 | $168.44 | −$209K | 16,020 |
| Sanzone Virginia Ruth | VP, General Counsel | Sep 03 | Disclosed 10b5-1 sale · S | −2,202 | $167.67 | −$369K | 17,258 |
| Bonnell Brian Michael | Chief Financial Officer | Sep 01 | Disclosed 10b5-1 sale · S | −6,381 | $175.00 | −$1.12M | 56,062 |
| Bonnell Brian Michael | Chief Financial Officer | Aug 31 | Disclosed 10b5-1 sale · S | −1,113 | $173.91 | −$194K | 62,443 |
| Bonnell Brian Michael | Chief Financial Officer | Aug 31 | Disclosed 10b5-1 sale · S | −4,568 | $173.44 | −$792K | 63,556 |
| Bonnell Brian Michael | Chief Financial Officer | Aug 31 | Disclosed 10b5-1 sale · S | −1,914 | $172.12 | −$329K | 68,124 |
| Bonnell Brian Michael | Chief Financial Officer | Aug 31 | Disclosed 10b5-1 sale · S | −1,712 | $171.05 | −$293K | 70,038 |
| Woolson Daniel | VP, GM-Infusion Capital | Aug 13 | Open-market sale · S | −5,417 | $181.33 | −$982K | 17,062 |
| Sousa Ben | Chief Information Officer | Aug 12 | Open-market sale · S | −2,250 | $178.32 | −$401K | 3,076 |
| Finney Elisha W | Director | Aug 11 | Open-market sale · S | −378 | $182.48 | −$69K | 4,871 |
| Voigtlander Christian B. | Chief Operating Officer | Aug 11 | Open-market sale · S | −8,929 | $182.93 | −$1.63M | 37,377 |
| Woolson Daniel | President | May 22 | Open-market sale · S | −2,123 | $132.21 | −$281K | 22,479 |
| Sanzone Virginia Ruth | VP, General Counsel | May 14 | Open-market sale · S | −2,447 | $124.08 | −$304K | 19,460 |
| Finney Elisha W | Director | May 13 | Exercise / conversion · M | +1,254 | — | — | 5,249 |
| Hoffmeister David F | Director | May 13 | Exercise / conversion · M | +1,254 | — | — | 6,004 |
| Kennedy Kolleen T | Director | May 13 | Exercise / conversion · M | +1,254 | — | — | 4,539 |
| Abbey Donald | Director | May 13 | Exercise / conversion · M | +1,254 | — | — | 6,004 |
| Greenberg David C. | Director | May 13 | Exercise / conversion · M | +1,254 | — | — | 9,214 |
Loading...
